693 Safety and Efficacy Results from an Open-Label Phase 1b/2 Study of RP1 Oncolytic Immunotherapy in Solid Organ Transplant Recipients with Advanced Cutaneous Malignancies (ARTACUS)
Regular and Young Investigator Award Abstracts（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined